The global use of TCM has been steadily increasing,yet Chinese TCM products still face significant challenges in entering international markets,including cultural differences between East and West,inadequate quality standards for TCM,regulatory barriers against herbal medicines,and the substandard quality of medicinal materials.The 2022 edition of Chinese Herbal Medicine Production Quality Management Code introduced the concept of Hazard Analysis and Critical Control Points(HACCP)to control the harmful factors in the production of Chinese herbal medicine;at the same time,the international standard of TCM was established after the establishment of ISO/TC249 to control the quality of TCM from the source by carrying out GAP and ISO double certification,which is the fundamental way for Chinese TCM to expand its international market share.This study conducted a comparative analysis of the application status of three key systems—GAP(Good Agricultural Practices),HACCP and ISO(International Organization for Standardization)—in the quality control of TCM.Based on this analysis,this article proposed that China's TCM production standards should draw upon the strengths of these international quality management systems to reduce production risks and costs while enhancing the practicality and implementation of GAP guidelines.

Body weight abnormalities, including overweight, obesity, and underweight, have become a dual public health challenge in Chinese adults: overweight and obesity lead to a variety of chronic complications, while underweight increases the risks of malnutrition, sarcopenia, and organ dysfunction. To systematically address these issues, multidisciplinary experts in endocrinology, sports science, nutrition, and psychiatry from various regions have held multiple weight management seminars. Based on the latest epidemiological data and clinical evidence, they expanded the guideline to include assessment and intervention strategies for underweight, in addition to the core content of obesity management. This guideline outlines the etiological mechanisms, evaluation methods, and multidimensional management strategies for overweight and obesity, covering key areas such as diagnosis and assessment, medical nutrition therapy, exercise prescription, pharmacological intervention, and psychological support. It is intended to provide a scientific and standardized approach to weight management across the adult population, aiming to curb the rising prevalence of obesity, mitigate complications associated with abnormal body weight, and improve nutritional status and overall quality of life.

Osteosarcoma is a primary bone tumor originating from mesenchymal tissues,highly aggressive and metastatic,and is one of the causes of orthopedic disorders in children and adolescents.The establishment of an osteosarcoma model is useful for studying the changes in the physiology and pathology of the organism after the occurrence of osteosarcoma.The establishment methods of osteosarcoma models not only differ in terms of difficulty,tumorigenicity,tumor-formation time,tumor survival time,tumor metastasis,and safety,but also in terms of simulating human osteosarcoma biological characteristics and histological features.In addition,the wide application of tissue engineering in tumor modeling is conducive to better study the role of the osteosarcoma microenvironment in osteosarcoma genesis and development.In this paper,we summarize the roles of different osteosarcoma animal models and their tissue engineering models in different experiments,in order to provide help for the study of osteosarcoma pathogenesis and drug intervention mechanism.

Osteosarcoma is a primary bone tumor originating from mesenchymal tissues,highly aggressive and metastatic,and is one of the causes of orthopedic disorders in children and adolescents.The establishment of an osteosarcoma model is useful for studying the changes in the physiology and pathology of the organism after the occurrence of osteosarcoma.The establishment methods of osteosarcoma models not only differ in terms of difficulty,tumorigenicity,tumor-formation time,tumor survival time,tumor metastasis,and safety,but also in terms of simulating human osteosarcoma biological characteristics and histological features.In addition,the wide application of tissue engineering in tumor modeling is conducive to better study the role of the osteosarcoma microenvironment in osteosarcoma genesis and development.In this paper,we summarize the roles of different osteosarcoma animal models and their tissue engineering models in different experiments,in order to provide help for the study of osteosarcoma pathogenesis and drug intervention mechanism.

The global use of TCM has been steadily increasing,yet Chinese TCM products still face significant challenges in entering international markets,including cultural differences between East and West,inadequate quality standards for TCM,regulatory barriers against herbal medicines,and the substandard quality of medicinal materials.The 2022 edition of Chinese Herbal Medicine Production Quality Management Code introduced the concept of Hazard Analysis and Critical Control Points(HACCP)to control the harmful factors in the production of Chinese herbal medicine;at the same time,the international standard of TCM was established after the establishment of ISO/TC249 to control the quality of TCM from the source by carrying out GAP and ISO double certification,which is the fundamental way for Chinese TCM to expand its international market share.This study conducted a comparative analysis of the application status of three key systems—GAP(Good Agricultural Practices),HACCP and ISO(International Organization for Standardization)—in the quality control of TCM.Based on this analysis,this article proposed that China's TCM production standards should draw upon the strengths of these international quality management systems to reduce production risks and costs while enhancing the practicality and implementation of GAP guidelines.

Body weight abnormalities, including overweight, obesity, and underweight, have become a dual public health challenge in Chinese adults: overweight and obesity lead to a variety of chronic complications, while underweight increases the risks of malnutrition, sarcopenia, and organ dysfunction. To systematically address these issues, multidisciplinary experts in endocrinology, sports science, nutrition, and psychiatry from various regions have held multiple weight management seminars. Based on the latest epidemiological data and clinical evidence, they expanded the guideline to include assessment and intervention strategies for underweight, in addition to the core content of obesity management. This guideline outlines the etiological mechanisms, evaluation methods, and multidimensional management strategies for overweight and obesity, covering key areas such as diagnosis and assessment, medical nutrition therapy, exercise prescription, pharmacological intervention, and psychological support. It is intended to provide a scientific and standardized approach to weight management across the adult population, aiming to curb the rising prevalence of obesity, mitigate complications associated with abnormal body weight, and improve nutritional status and overall quality of life.

Critically ill patients are at high risk for hospital acquired infections, which can significantly increase the mortality rate and treatment costs for these patients. Therefore, in the process of treating the primary disease, strict prevention and control of new hospital infections is an essential component of the treatment for critically ill patients. The treatment of critically ill patients involves multiple steps and requires a concerted effort from various aspects such as theory, management, education, standards, and supervision to achieve effective prevention and control of hospital infections. However, there is currently a lack of unified understanding and standards for hospital infection prevention and control. To address this, in March 2024, a group of experts in critical care medicine, infectious diseases, and hospital infection from China discussed the current situation and issues of hospital infection control in the intensive care unit together. Based on a review of the latest evidence-based medical evidence from both domestic and international sources, 2024 Expert Consensus on Hospital Acquired Infection Control Principles in the Department of Critical Care Medicine was formed, aiming to provide a basis for the development of hospital infection prevention and control strategies in the field of critical care medicine.

Objective Genotypes(G)1,3,and 5 of the Japanese encephalitis virus(JEV)have been isolated in China,but the dominant genotype circulating in Chinese coastal areas remains unknown.We searched for G5 JEV-infected cases and attempted to elucidate which JEV genotype was most closely related to human Japanese encephalitis(JE)in the coastal provinces of China. Methods In this study,we collected serum specimens from patients with JE in three coastal provinces of China(Guangdong,Zhejiang,and Shandong)from 2018 to 2020 and conducted JEV cross-neutralization tests against G1,G3,and G5. Results Acute serum specimens from clinically reported JE cases were obtained for laboratory confirmation from hospitals in Shandong(92 patients),Zhejiang(192 patients),and Guangdong(77 patients),China,from 2018 to 2020.Seventy of the 361 serum specimens were laboratory-confirmed to be infected with JEV.Two cases were confirmed to be infected with G1 JEV,32 with G3 JEV,and two with G5 JEV. Conclusion G3 was the primary infection genotype among JE cases with a definite infection genotype,and the infection caused by G5 JEV was confirmed serologically in China.

Objective:To translate the Family Caregiver Conflict Scale (FCCS) into Chinese and test its reliability and validity.Methods:Based on the Brislin model, the Chinese version of FCCS was formed by conducting proper translation, back translation, proofreading, expert consultation, and pre-investigation. From January to May 2023, convenience sampling was used to select 240 caregivers of stroke inpatients in the Neurology Department of Xinjiang Uygur Autonomous Region People's Hospital as the research subject to test the reliability and validity of the scale. After 14 days, 30 caregivers were randomly selected for retesting. A total of 240 questionnaires were distributed, and 232 valid questionnaires were collected, with an effective response rate of 96.667%.Results:The Chinese version of FCCS consisted of 15 items. The item-level content validity index were 0.833 to 1.000, and the scale-level content validity index was 0.933. Exploratory factor analysis extracted three common factors, with a cumulative variance contribution rate of 74.668%. The total Cronbach's α coefficient of the scale was 0.920, with Cronbach's α coefficients for each dimension ranging from 0.823 to 0.951. The Guttman half coefficient was 0.821. The test-retest reliability coefficient of the total scale was 0.882, and the test-retest reliability coefficients for each dimension ranged from 0.622 to 0.825.Conclusions:The Chinese version of FCCS has good reliability and validity, and can be used as an assessment tool for family conflicts in caregivers of stroke patients.

Osteosarcoma is a common primary malignant bone tumor with highly aggressive and distal metastasis and poor prognosis. Abnormal metabolism of iron, an essential nutrient with electron-exchange capacity and an important participant in cellular activities, is closely associated with the progression of osteosarcoma. Ferroptosis has been shown to regulate osteosarcoma progression and play an important role in the treatment of osteosarcoma. Exploring the application of relevant molecular mechanisms of ferroptosis in osteosarcoma and the current status of pharmacological intervention may provide new strategies for the treatment of osteosarcoma.